Right to FDA-Approved Medicines Act

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 4525 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 4525 To protect an individuals ability to access medicines approved by the Food and Drug Administration to protect a health care providers ability to provide such medicines, and information related to such medicines. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES July 17, 2025 Ms. Ross (for herself, Ms. Schrier, Ms. Castor of Florida, Mrs. Trahan, and Mrs. Fletcher) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To protect an individuals ability to access medicines approved by the Food and Drug Administration to protect a health care providers ability to provide such medicines, and information related to such medicines. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Right to FDA-Approved Medicines Act''. SEC. 2. DEFINITIONS. In this Act: (1) FDA-approved medicine.--The term ``FDA-approved medicine'' means any drug approved under section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) or licensed under section 351 of the Public Health Service Act (42 U.S.C. 262). (2) Government.--The term ``government'' includes each branch, department, agency, instrumentality, and official of the United States or a State. (3) Health care provider.--The term ``health care provider'' means any entity or individual (including any physician, certified nurse-midwife, nurse, nurse practitioner, physician assistant, and pharmacist) that is licensed or otherwise authorized by a State to prescribe FDA-approved medicines. (4) State.--The term ``State'' includes each of the 50 States, the District of Columbia, the Commonwealth of